Current Report Filing (8-k)
2022年6月16日 - 3:34AM
Edgar (US Regulatory)
0001509957
false
0001509957
2022-06-09
2022-06-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
June
9, 2022
Date
of Report (Date of earliest event reported)
Can
B̅ Corp.
(Exact
name of registrant as specified in its charter)
Florida |
|
000-55753 |
|
20-3624118 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
960
South Broadway, Suite 120
Hicksville,
NY |
|
11801 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code 516-595-9544
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written
communications pursuant to Rule 425 under Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
None |
|
CANB |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01 Entry into a Material Definitive Agreement.
Securities
Purchase Documents
On
June 9, 2022, Can B Corp., a Florida corporation (the “Company”) entered into a definitive agreement (the “Agreement”)
with an investor (“Investor”) for the sale of a promissory note (“Note”) and warrants (“Warrants”)
to Investor for total consideration of $56,250.
The
Note is in the principal amount of $62,500 with an original issue discount of 10%. The Note is convertible into common stock of the Company
at a price per share of $4.00, subject to adjustment pursuant to the terms of the Note. The Note bears interest at the rate of 12% per
year, which increases to 16% per year in the event of default. The Company has agreed to pay $500 to Investor for each conversion under
the Note to cover its expenses related thereto. The Company has agreed to reserve at least two times the number of shares convertible
under the Note at all times and has entered into an irrevocable letter agreement with its transfer agent to issue Investor shares resulting
from its conversion of the Note and exercise of Warrants. In the event that the Company issues common stock or securities convertible
into common stock at a price per share less than the conversion price under the Note, the Note’s conversion price will be decreased
to match such dilutive issuance; provided that, in the event a dilutive issuance occurs in the first 180 days after Note issuance, such
adjustment will not be applied until the date 180 days after the Note is issued. The Note contains similar most favored nations terms
where the adjustments will take place, if any, no sooner than 180 days after the Note is issued. The Company may prepay the Note subject
to a 10% prepayment penalty and shall repay all of the Note in the event its current S-1 offering, as amended, is declared effective
by the Securities and Exchange Commission (“SEC”) and shall repay at least 50% of the Note in the event of an alternative
financing occurring after the company has raised at least $1,250,000 in bridge financing. The Company has agreed to offer Investor the
first right to participate in future financings. The Note otherwise contains default and other restrictive terms typical of debt finance
deals of this nature. The Note may be accelerated upon an event of default.
In
conjunction with the issuance of the Note to Investor, the Company also issued Investor Warrants to purchase 9,766 shares of common stock
at a price per share of $6.40. However, if within 180 days after the Warrant issuance the Company’s current S-1 offering, as amended,
is declared effective by the SEC, the exercise price will be adjusted to 120% of the offering price per unit or share offered. The Company
has agreed to register the common stock issuable upon exercise of the Warrant with the SEC pursuant to a registration rights agreement.
If the shares are not so registered within 180 days from Warrant issuance, the Warrant shall have a cashless exercise feature. No fractional
shares will be issued upon exercise of any portion of the Warrant. There are penalties to the Company in the event it does not timely
issue shares upon exercise of the Warrant. The Warrant has anti-dilution terms similar to the Warrant, except that if the Company’s
current S-1 offering, as amended, is declared effective by the SEC and the Note is paid in full, the exercise price shall never be adjusted
due to a dilutive issuance.
In
addition to the foregoing, the Company has agreed to pay $5,000 in Investor’s legal fees and to grant Investor piggyback registration
rights requiring the Company to register all common shares held by Investor resulting from conversion of the Note or exercise of the
Warrants in the event it files a registration statement with the SEC, excluding certain types of registration statements where such piggyback
rights would not apply. Otherwise, the Note, Warrants, registration rights agreement and Agreement contain covenants, representations
and warranties typical of transactions of this type. All such agreements are governed by Delaware law.
The
foregoing descriptions of definitive agreements are qualified in their entirety by the terms of the full text of the agreements, respectively,
attached hereto as exhibits.
Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
See
item 1.01 regarding the Investor Note and the obligations of the Company relating thereto.
Item
3.02 Unregistered Sales of Equity Securities.
See
Item 1.01 for discussion of the Note and Warrants issued to Investor. The foregoing securities were issued in reliance upon the exemption
from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”), as amended,
and Regulation D as promulgated under the Securities Act.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed herewith.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
June 15, 2022 |
Can B̅ Corp. |
|
|
|
|
By: |
/s/
Marco Alfonsi |
|
|
Marco
Alfonsi, CEO |
CAN B (QB) (USOTC:CANB)
過去 株価チャート
から 2 2025 まで 3 2025
CAN B (QB) (USOTC:CANB)
過去 株価チャート
から 3 2024 まで 3 2025
Real-Time news about CAN B Corporation (QB) (その他OTC): 0 recent articles
その他のCan B Corpニュース記事